NASDAQ:RTIX - RTI Surgical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.70 -0.10 (-2.08 %)
(As of 07/16/2018 03:06 AM ET)
Previous Close$4.70
Today's Range$4.70 - $4.85
52-Week Range$3.85 - $5.90
Volume96,649 shs
Average Volume156,764 shs
Market Capitalization$298.11 million
P/E Ratio67.14
Dividend YieldN/A
Beta1.56
RTI Surgical logoRTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

Receive RTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for RTIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:RTIX
CUSIP74975N10
Phone386-418-8888

Debt

Debt-to-Equity Ratio0.31
Current Ratio3.81
Quick Ratio1.53

Price-To-Earnings

Trailing P/E Ratio67.14
Forward P/E Ratio47.00
P/E Growth3.13

Sales & Book Value

Annual Sales$279.56 million
Price / Sales1.07
Cash Flow$0.2686 per share
Price / Cash17.50
Book Value$2.99 per share
Price / Book1.57

Profitability

EPS (Most Recent Fiscal Year)$0.05
Net Income$6.27 million
Net Margins2.57%
Return on Equity2.49%
Return on Assets1.24%

Miscellaneous

Employees942
Outstanding Shares63,430,000
Market Cap$298.11

The Truth About Cryptocurrencies

RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions

What is RTI Surgical's stock symbol?

RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."

How were RTI Surgical's earnings last quarter?

RTI Surgical Inc (NASDAQ:RTIX) issued its quarterly earnings results on Thursday, May, 3rd. The medical equipment provider reported $0.01 EPS for the quarter, hitting analysts' consensus estimates of $0.01. The medical equipment provider had revenue of $69.89 million for the quarter, compared to analyst estimates of $68.70 million. RTI Surgical had a net margin of 2.57% and a return on equity of 2.49%. View RTI Surgical's Earnings History.

When is RTI Surgical's next earnings date?

RTI Surgical is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for RTI Surgical.

What is the consensus analysts' recommendation for RTI Surgical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of RTI Surgical's key competitors?

Who are RTI Surgical's key executives?

RTI Surgical's management team includes the folowing people:
  • Mr. Camille I. Farhat, CEO, Pres & Director (Age 48)
  • Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 54)
  • Mr. John N. Varela, Exec. VP of Global Operations (Age 51)
  • Mr. Kevin D. Brandt, Chief Commercial Officer of Domestic Direct and Exec. VP (Age 52)
  • Mr. Johannes Wynand Louw, VP of Fin. & Corp. Controller

Has RTI Surgical been receiving favorable news coverage?

News articles about RTIX stock have trended positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.33 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 46.26 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of RTI Surgical?

Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is RTI Surgical's stock price today?

One share of RTIX stock can currently be purchased for approximately $4.70.

How big of a company is RTI Surgical?

RTI Surgical has a market capitalization of $298.11 million and generates $279.56 million in revenue each year. The medical equipment provider earns $6.27 million in net income (profit) each year or $0.05 on an earnings per share basis. RTI Surgical employs 942 workers across the globe.

How can I contact RTI Surgical?

RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]


MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  387
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.